Biosimilar Access: Is The Industry Overlooking Critical Markets?
Anna Rose Welch interviews Jayasree K. Iyer and writes about biosimilar development and the work of the Foundation on assessing pharmaceutical company action to improve access to cancer care in low- and middle-income countries.